Edgewise Therapeutics
EWTX
EWTX
78 hedge funds and large institutions have $294M invested in Edgewise Therapeutics in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 28 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
44% less capital invested
Capital invested by funds: $524M → $294M (-$230M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
78
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.28M | |
| 2 | +$2.7M | |
| 3 | +$2.34M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$1.4M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.18M |
Top Sellers
| 1 | -$25.4M | |
| 2 | -$6.63M | |
| 3 | -$6.43M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$2.93M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$810K |